Retinoic acid for treatment of multicentric Castleman's disease

Lancet. 1999 Oct 9;354(9186):1262-3. doi: 10.1016/S0140-6736(99)03957-4.

Abstract

Multicentric Castleman's syndrome has an aggressive course with poor prognosis, and its treatment remains uncertain. We report a woman with multicentric Castleman's disease that was successfully treated with prednisone and retinoic acid.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Castleman Disease / drug therapy*
  • Castleman Disease / physiopathology
  • Female
  • Humans
  • Prednisone / therapeutic use*
  • Tretinoin / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Tretinoin
  • Prednisone